News
News
- MDxHealth Reports Financial Year 2020 Results and Provides Outlook for 2021
07:00 - GlobeNewswire - iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock
06:47 - GlobeNewswire - ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares
06:42 - GlobeNewswire - Beyond Meat, Inc. Prices Upsized $1 Billion Convertible Senior Notes Offering
05:33 - GlobeNewswire - KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII), A New Once-Daily Treatment for ADHD
05:31 - GlobeNewswire - Cardlytics Announces Pricing of Public Offering of Common Stock
03:55 - GlobeNewswire - Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
02:25 - GlobeNewswire - Twelve Seas Investment Company II Announces Closing of $300,000,000 Initial Public Offering
01:30 - GlobeNewswire - HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Infinity Q Diversified Alpha Fund (IQDAX; IQDNX) Investors with Losses to Contact Its Attorneys, Fund Halts Redemptions and Suspends Chief Investment Officer
01:12 - GlobeNewswire - INDUS Announces Pricing of Public Offering of Common Stock
01:00 - GlobeNewswire
Real-time